However, in a recent study by Zelin Liu et al. (2022), SLC4A4 knockdown in prostate cancer (PCa) inhibited cell proliferation, migration, and invasion while facilitating apoptosis. This evidence concerns the gene SLC4A4 and prostate carcinoma.